Literature DB >> 19252234

Dexamethasone attenuated endotoxin-induced acute lung injury through inhibiting expression of inducible nitric oxide synthase.

Zhui Yu1, Jing-Ping Ouyang, Yin-Ping Li.   

Abstract

Application of glucocorticoids in sepsis or severe infection is disputable in clinic. In this experiment, we studied the effect of dexamethasone on nitric oxide synthases and whether dexamethasone could attenuate endotoxin-induced acute lung injury (ALI). SD rats received 5 mg/kg lipopolisaccharide (LPS) injection. Then arterial oxygen partial pressure (PaO2), lung histology, lung tissue nitric oxide (NO) production and expression of nitric oxide synthases (NOS) were detected at 0.5, 1, 2, 3 or 4 h after LPS injection. PaO2 and lung injury deteriorated upon time. Production of NO in lung tissue increased significantly particularly in the first two hours, and this change was mainly due to the over-expression of inducible NOS (iNOS), but not endothelial NOS (eNOS). Furthermore, a tight positive correlation was observed between lung injury score (LIS) and NO production level in lung tissue. Dexamethasone could ameliorate PaO2 and lung damage evidently, which were paralleled by significant decreases in the production of NO and in the expression of iNOS mRNA. In conclusion, dexamethasone could effectively attenuate endotoxin-induced lung injury through inhibiting iNOS expression and activation in the very early stage of ALI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252234     DOI: 10.3233/CH-2009-1162

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  9 in total

1.  Protective effects of dexamethasone on early acute lung injury induced by oleic acid in rats.

Authors:  Bin Huang; Dao-Xin Wang; Wang Deng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

3.  Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.

Authors:  Robert Bucki; Katarzyna Leszczynska; Fitzroy J Byfield; David E Fein; Esther Won; Katrina Cruz; Andrzej Namiot; Alina Kulakowska; Zbigniew Namiot; Paul B Savage; Scott L Diamond; Paul A Janmey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

4.  The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes.

Authors:  Lioudmila V Karnatovskaia; Augustine S Lee; Ognjen Gajic; Emir Festic
Journal:  Crit Care Med       Date:  2013-07       Impact factor: 7.598

5.  Behavioral and neuronal biochemical possible effects in experimental induced chronic mild stress in male albino rats under the effect of oral barley administration in comparison to venlafaxine.

Authors:  Inas E Darwish; Hala M Maklad; Iman H Diab
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27

6.  Efficacy and safety of low-dose corticosteroids for acute respiratory distress syndrome: A systematic review and meta-analysis.

Authors:  Yu-Qing Cui; Xian-Fei Ding; Huo-Yan Liang; Dong Wang; Xiao-Juan Zhang; Li-Feng Li; Quan-Cheng Kan; Le-Xin Wang; Tong-Wen Sun
Journal:  World J Emerg Med       Date:  2021

Review 7.  Sepsis-induced cardiomyopathy.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Julian Gil-Cebrian; Maria J Huertos-Ranchal
Journal:  Curr Cardiol Rev       Date:  2011-08

8.  Comparative Effects of Dexamethasone and Meloxicam on Magnitude of the Acute Inflammatory Response Induced by Escherichia coli Lipopolysaccharide in Broiler Chickens.

Authors:  Mohadeseh Manzari Tavakoli; Bahman Abdi-Hachesoo; Saeed Nazifi; Najmeh Mosleh; Seyedeh Alemeh Hosseinian; Peyman Nakhaee
Journal:  J Inflamm Res       Date:  2020-08-24

9.  Levocetirizine Pretreatment Mitigates Lipopolysaccharide-Induced Lung Inflammation in Rats.

Authors:  Alaa N A Fahmi; George S G Shehatou; Hatem A Salem
Journal:  Biomed Res Int       Date:  2018-08-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.